Literature DB >> 21568698

Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis.

Tobias Klatte1, Julian Mauermann, Gertraud Heinz-Peer, Matthias Waldert, Peter Weibl, Hans Christoph Klingler, Mesut Remzi.   

Abstract

PURPOSE: To directly compare perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy using a matched pair analysis. PATIENTS AND METHODS: A total of 41 patients who underwent laparoscopic cryoablation for an incidental, solid clinical T(1a)N(0)M(0) renal tumor were matched with 82 patients who received partial nephrectomy in cold ischemia, using optimal matching based on propensity scores, which were created on the basis of preoperative aspects and dimensions used for an anatomic classification of renal tumors (PADUA) score, preoperative glomerular filtration rate, age-adjusted Charlson comorbidity index, and sex. Median follow-up was 33.6 months.
RESULTS: No differences in the overall incidence of complications (cryoablation, 20%; partial nephrectomy, 17%; P=0.739) and grade of complications (P=0.424) were observed. After cryoablation, local recurrence developed in four patients with renal-cell carcinoma (n=35) after a median duration of 14 months (range 6-18  mos), but none after partial nephrectomy. The 3-year recurrence-free survival probabilities after laparoscopic renal cryoablation vs open partial nephrectomy were 83% vs 100%, respectively (P=0.015). The average decrease of estimated glomerular filtration rate during follow-up was 7.8±3.1  mL/min/1.73  m(2) after laparoscopic cryoablation and 9.8±2.3  mL/min/1.73  m(2) after open partial nephrectomy, which was not statistically significant (P=0.602).
CONCLUSIONS: Perioperative complications and renal functional outcomes of laparoscopic cryoablation and open partial nephrectomy are similar; however, laparoscopic cryoablation confers a substantially higher local recurrence risk of about 17% after 3 years. Therefore, laparoscopic renal cryoablation should be reserved for high-risk patients with decreased life expectancy. Careful patient counseling is advocated. Study limitations include the small sample size, the lack of randomization, and the short follow-up.

Entities:  

Mesh:

Year:  2011        PMID: 21568698     DOI: 10.1089/end.2010.0615

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  13 in total

Review 1.  Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.

Authors:  Serge Ginzburg; Jeffrey J Tomaszewski; Alexander Kutikov
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

Review 2.  Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.

Authors:  Hiten D Patel; Phillip M Pierorazio; Michael H Johnson; Ritu Sharma; Emmanuel Iyoha; Mohamad E Allaf; Eric B Bass; Stephen M Sozio
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-08       Impact factor: 8.237

Review 3.  Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis.

Authors:  Phillip M Pierorazio; Michael H Johnson; Hiten D Patel; Stephen M Sozio; Ritu Sharma; Emmanuel Iyoha; Eric B Bass; Mohamad E Allaf
Journal:  J Urol       Date:  2016-05-06       Impact factor: 7.450

Review 4.  Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses.

Authors:  Christopher J Long; Daniel J Canter; Marc C Smaldone; Tianyu Li; Jay Simhan; Boris Rozenfeld; Ervin Teper; David Y T Chen; Richard E Greenberg; Rosalia Viterbo; Robert G Uzzo; Alexander Kutikov
Journal:  Can J Urol       Date:  2012-10       Impact factor: 1.344

5.  Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis.

Authors:  Johannes Uhlig; Arne Strauss; Gerta Rücker; Ali Seif Amir Hosseini; Joachim Lotz; Lutz Trojan; Hyun S Kim; Annemarie Uhlig
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

Review 6.  [Focal therapy for small renal masses : Observation, ablation or surgery].

Authors:  J J Wendler; B Friebe; D Baumunk; A Blana; T Franiel; R Ganzer; B Hadaschik; T Henkel; K U Köhrmann; J Köllermann; T Kuru; S Machtens; A Roosen; G Salomon; H P Schlemmer; L Sentker; U Witzsch; U B Liehr; J Ricke; M Schostak
Journal:  Urologe A       Date:  2016-05       Impact factor: 0.639

Review 7.  The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.

Authors:  Tobias Klatte; Nils Kroeger; Uwe Zimmermann; Martin Burchardt; Arie S Belldegrun; Allan J Pantuck
Journal:  World J Urol       Date:  2014-04-04       Impact factor: 4.226

8.  Utilization and perioperative complications of laparoscopic cryoablation vs. robotic partial nephrectomy for localized renal tumors.

Authors:  Aaron C Weinberg; Solomon L Woldu; Timothy Wen; Christopher M Deibert; Ruslan Korets; Ketan K Badani
Journal:  Int Braz J Urol       Date:  2015 May-Jun       Impact factor: 1.541

Review 9.  Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies.

Authors:  Malte W Vetterlein; Tarun Jindal; Andreas Becker; Marc Regier; Luis A Kluth; Derya Tilki; Felix K-H Chun
Journal:  Investig Clin Urol       Date:  2016-07-05

Review 10.  Indications for biopsy and the current status of focal therapy for renal tumours.

Authors:  Ricardo R N Leão; Patrick O Richard; Michael A S Jewett
Journal:  Transl Androl Urol       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.